anmelden
BX Swiss TOP 30 CHF
1.511,12
PKT
+2,60
PKT
+0,17
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.10.12 | Swiss Re buy | Vontobel Research | |
| 18.10.12 | Roche outperform | Credit Suisse Group | |
| 18.10.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 18.10.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 18.10.12 | UBS overweight | Morgan Stanley | |
| 18.10.12 | UBS equal-weight | Morgan Stanley | |
| 18.10.12 | Julius Bär equal-weight | Morgan Stanley | |
| 18.10.12 | Swiss Life buy | Nomura | |
| 18.10.12 | Givaudan sell | Goldman Sachs Group Inc. | |
| 18.10.12 | Roche overweight | J.P. Morgan Cazenove | |
| 18.10.12 | Nestlé buy | Sarasin Research | |
| 18.10.12 | Givaudan outperform | Exane-BNP Paribas SA | |
| 18.10.12 | UBS buy | Deutsche Bank AG | |
| 18.10.12 | UBS hold | Deutsche Bank AG | |
| 18.10.12 | Straumann hold | Vontobel Research | |
| 18.10.12 | Nestlé outperform | Cheuvreux SA | |
| 18.10.12 | Nestlé hold | Vontobel Research | |
| 18.10.12 | Zurich Insurance hold | Société Générale Group S.A. (SG) | |
| 18.10.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 18.10.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 18.10.12 | Zurich Insurance outperform | Keefe, Bruyette & Woods, Inc. | |
| 17.10.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.10.12 | Zurich Insurance halten | Independent Research GmbH | |
| 17.10.12 | Roche outperform | Exane-BNP Paribas SA | |
| 17.10.12 | Novartis reduce | Vontobel Research | |
| 17.10.12 | Givaudan hold | Vontobel Research | |
| 17.10.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 17.10.12 | Zurich Insurance neutral | Sarasin Research | |
| 17.10.12 | Zurich Insurance hold | Vontobel Research | |
| 16.10.12 | Roche outperform | Cheuvreux SA | |
| 16.10.12 | Nestlé neutral | Credit Suisse Group | |
| 16.10.12 | Novartis neutral | Citigroup Corp. | |
| 16.10.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 16.10.12 | Novartis underperform | Banc of America Securities-Merrill Lynch | |
| 16.10.12 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 16.10.12 | ABB (Asea Brown Boveri) hold | Société Générale Group S.A. (SG) | |
| 16.10.12 | Kühne + Nagel International equal-weight | Morgan Stanley | |
| 16.10.12 | Kühne + Nagel International hold | Deutsche Bank AG | |
| 16.10.12 | Nestlé overweight | Morgan Stanley | |
| 16.10.12 | Kühne + Nagel International buy | Nomura |
